Clinical Trial Update: Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the efficacy and safety of R NIMP in relapsed aggressive lymphomas, including diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R NIMP

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED